Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors

Y Kajikawa, M Ikeda, S Takemoto, J Tomoda… - International heart …, 2011 - jstage.jst.go.jp
The aim of this study was to investigate the associations of adiponectin and leptin with
metabolic syndrome (MetS) and coronary heart disease (CHD) in patients with various …

Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions.

A Tamura, S Kusachi, K Nogami, A Yamanishi… - Heart, 1996 - heart.bmj.com
OBJECTIVE: To examine the hypothesis that tenascin, an extracellular matrix glycoprotein,
contributes to fibrotic changes in dilated cardiomyopathy. METHODS: The localisation of …

Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction

M Nakashima, T Miyoshi, K Ejiri, H Kihara… - ESC heart …, 2022 - Wiley Online Library
Aims Sodium glucose co‐transporter 2 inhibitors have diuretic effects in both patients with
glycosuria and with natriuresis. We sought to assess the effect of luseogliflozin on estimated …

Sequential changes in the distribution of type I and III collagens in the infarct zone: immunohistochemical study of experimental myocardial infarction in the rat

K Inoue, S Kusachi, K Niiya, Y Kajikawa… - Coronary Artery …, 1995 - journals.lww.com
Aim Ventricular remodeling following acute myocardial infarction is an important factor in
prognosis. The healing process, involving changes in type I and III collagens, is one of the …

Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure

M Iguchi, H Wada, T Shinozaki, M Suzuki… - ESC Heart …, 2021 - Wiley Online Library
Aims Endothelial cell vascular endothelial growth factor receptor 2 (VEGFR‐2) plays a
pivotal role in angiogenesis, which induces physiological cardiomyocyte hypertrophy via …

Comparable effect of aliskiren or a diuretic added on an angiotensin II receptor blocker on augmentation index in hypertension: a multicentre, prospective, randomised …

T Miyoshi, T Murakami, S Sakuragi, M Doi, S Nanba… - Open …, 2017 - openheart.bmj.com
Background The effects of antihypertensive drug combination therapy on central blood
pressure (BP) and augmentation index (AI) have not been fully elucidated. We investigated …

Asymptomatic double aortic arch

Y Kajikawa, S Takemoto, Y Suganami, M Inoue - Internal medicine, 2005 - jstage.jst.go.jp
Asymptomatic Double Aortic Arch Toggle navigation J-STAGE home 資料・記事を探す 資料を
探す:資料タイトルから 資料を探す:分野から 資料を探す:発行機関から 記事を探す データを探す(J-STAGE …

NG-nitro-L-arginine attenuates flow debt repayment in the reactive hyperemic response of the open-chest dog coronary artery: contribution of endothelium-derived …

M Marutani, S Kusachi, Y Kajikawa… - Acta Medica …, 1992 - europepmc.org
To test the hypothesis that the endothelium-derived relaxing factor (EDRF) contributes to
coronary vasodilation induced by myocardial ischemia, we examined the effect of NG-nitro-L …

Serial Measurement of Vascular Endothelial Growth Factor-D in Heart Failure: The PREHOSP-CHF Study

M Iguchi, H Wada, T Shinozaki, masahiro suzuki… - Circulation, 2023 - Am Heart Assoc
Background: Vascular endothelial growth factor-D (VEGF-D) is a secreted glycoprotein that
can act as lymphangiogenic and angiogenic growth factors. We recently reported that VEGF …

Anticoagulant Effects of Edoxaban in Cancer and Non-Cancer Patients With Venous Thromboembolism

M Yoshida, K Kuroda, K Tokioka, K Hatanaka… - Circulation, 2023 - Am Heart Assoc
Introduction: Edoxaban, a direct oral anticoagulant (DOAC), is established as an
anticoagulant medication in the treatment of venous thromboembolism (VTE) and …